PharmExec Blog
Follow Us
RSS
Bookstore
Author Archives: Julian Upton
The Most Influential Pharma Leader Or Institution?
Ahead of Pharm Exec’s 30th Anniversary Issue later this year, we are assembling a list of pharma leaders who have made the most impact on the industry.
Which individual(s) or institution(s) do you think has had the most influence of the industry in the last 10–30 years?
Please leave a comment in the box below or drop [...]
Warner-Chilcott's Cuts in Europe — Good News for US?
Any company announcing plans to ‘restructure’ and ‘repurpose’ itself tends to send out tremors across the industry, but for US employees of Dublin-headquartered Warner-Chilcott — the latest firm to use these tried and tested euphemisms — this could fuel a sigh of relief.
Value-Based Pricing Could Counter Innovation, Says UK Think Tank
The UK government’s proposals to introduce value-based pricing (VBP) — which aims to create a stronger link between the price the National Health Service pays for a medicine and the value it delivers (and in the process, ostensibly, further incentivize therapeutic innovation) — could actually serve to ‘hinder’ innovation, according to a UK think tank.
Posted in Europe, Global, R&D, pricing Tagged innovation, Pharma, PPRS, reimbursement, Stockholm Network, UK, value-based pricing Leave a comment
Assessing the Future State of Industry R&D: Panic, Prosperity or Both?
Home to a large segment of the global biopharma industry, the state of New Jersey has a significant stake in the future of medicines innovation. An annual symposium convened by the Rutgers University School of Business attempts to monitor the pulse of industry progress through an increasingly daunting thicket of commercial and policy challenges.
This year’s [...]
Posted in Events, Global Leave a comment
The Most Influential Pharma Leader Or Institution?